Skip to main content
Jeremie Calais, MD, Nuclear Medicine, Los Angeles, CA

Jeremie Calais MD PhD


Director, Clinical Research and Theranostics Programs

Join to View Full Profile
  • 200 Medical Plaza Suite B114Los Angeles, CA 90095

  • Phone+1 310-794-1005

  • Fax+1 310-206-7760

Dr. Calais is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Assistant Professor at the Ahmanson Translational Theranostics Division of the Department of Molecular and Medical Pharmacology. Dr. Calais received his MD degree from the University of Paris-Diderot in 2010. He subsequently trained in nuclear medicine and cancer imaging at the Henri Becquerel Cancer Center of the University of Rouen and was board certified by the French Society of Nuclear Medicine in 2014. His work focuses on improving the outcomes of cancer patients by translating and applying novel diagnostic and therapeutic approaches. He uses PET/CT imaging for cancer phenotyping, radiation therapy planning and therapy response assessment. He leads the clinical research program of Nuclear Medicine and Theranostics at UCLA that combines radionuclide therapy and imaging.
  • New Scan Finds Prostate Cancer Cells Hiding in the Body

    The test seems likely to improve the diagnosis and treatment of a disease that kills 33,000 American men each year. After doctors found cancer in Dr. Mark Sambe

Education & Training

  • University of Paris VII Faculty of Medicine
    University of Paris VII Faculty of MedicineClass of 2010

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2020 - 2024

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Dr. Adrien Holzgreve Named ‘One to Watch’ by Leading Nuclear Medicine and Molecular Imaging Organization
    Dr. Adrien Holzgreve Named ‘One to Watch’ by Leading Nuclear Medicine and Molecular Imaging OrganizationMay 6th, 2025
  • PSMA-PET/CT Detects Prostate Cancer Metastasis Missed by Conventional Imaging
    PSMA-PET/CT Detects Prostate Cancer Metastasis Missed by Conventional ImagingJanuary 15th, 2025
  • PSMA-PET Detects Hidden Metastasis in Recurrent Prostate Cancer
    PSMA-PET Detects Hidden Metastasis in Recurrent Prostate CancerJanuary 8th, 2025
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: